Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease
Open Access
- 21 December 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 9, 1123
Abstract
Background: Blood levels of immune markers have been proposed to discriminate patients with Parkinson's disease (PD) from controls. However, differences between clinical PD subgroups regarding these markers still need to be identified. Objective: To investigate whether clinical phenotypes can be predicted by the assessment of immune marker profiles in the serum of PD patients. Methods: Phenotypes of clinical PD from Tübingen, Germany (n = 145) and Toronto, Canada (n = 90) were defined regarding clinical subtype, disease onset, severity, and progression as well as presence of cognitive and/or autonomic dysfunction. A panel of serum immune markers was assessed using principal component analysis (PCA) and regression models to define the marker(s) that were associated with clinical phenotypes after adjusting for potential confounders. Findings of both centers were compared for validation. Further, a [18F] FEPPA-PET was performed in a group of patients with high and low values of candidate markers for the assessment of in vivo brain microglial activation. Results: Overall, serum immune markers did not cluster to define a pro/anti-inflammatory profile in PCA. Out of 25 markers only IL-12p40 showed a trend to discriminate between PD subgroups in both cohorts which could not be replicated by [18F] FEPPA-PET. Conclusions: Assessment of cytokines in serum does not reliably differentiate clinical PD subtypes. Accompanying subtype-irrelevant inflammation in PD, dual activity, and lack of specificity of the immune markers, the complex function of microglia, probable effects of treatment, disease stage, and progression on inflammation as well as current technical limitations may limit the usefulness of serum immune markers for the differentiation of subtypes.Keywords
This publication has 59 references indexed in Scilit:
- Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in SerumPLOS ONE, 2012
- Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?Journal of Neuroinflammation, 2012
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's DiseasePsychosomatics, 2010
- Association of the human leucocyte antigen region with susceptibility to Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson DiseasesAmerican Journal of Clinical Pathology, 2008
- Nitrated Alpha-Synuclein and Microglial Neuroregulatory ActivitiesJournal of Neuroimmune Pharmacology, 2008
- Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brainJournal of Neural Transmission, 2000
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996